Nationwide Children's Research News
Viewing: 341-350 of 380 | All
Apr 07, 2010
Study: Better Understanding of Abnormalities that Lead to Chronic Kidney Disease in Children
Kidney damage associated with chronic reflux is the fourth leading cause of chronic kidney disease and is the most common cause of severe hypertension in children.
Mar 01, 2010
New Gene Therapy Study Reverses Effects of Lethal Childhood Muscle Disorder in Mice
Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research shows.
Feb 01, 2010
New Study Finds Fingers Account for Majority of Pediatric Amputations
According to a new study conducted by researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children’s Hospital, there were more than 950 cases of traumatic amputations among children aged 17 years and younger in the United States in 2003.
Jan 11, 2010
Quality Transformation Collaborative Effort by Hospitals Saves Childrens Lives by Eradicating Bloodstream Infections
Catheter-associated blood stream infections (CA-BSIs) are infections that occur in hospitalized children’s central venous catheters (a catheter is flexible medical tubing inserted into the body).
Sep 28, 2009
Nationwide Childrens Hospital Designated Translational Research Center in CF Foundations National Clinical Trials Network
Nationwide Childrens Hospital has been selected to serve as one of 13 special translational research centers in a network of 77 clinical trial sites that are part of the Therapeutics Development Network (TDN) of the Cystic Fibrosis Foundation.The translational research centers will lead the newest
Jun 18, 2009
Nationwide Childrens Hospital Earns AAHRPP Accreditation for Safe Research Practices
The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has awarded Nationwide Childrens Hospital full accreditation as an organization that demonstrates and emphasizes clinical study participant safeguards that surpass state and federal requirements.Nationwide
Jun 11, 2009
Study Shows Promise for New Cancer-Stopping Therapy
Researchers at Nationwide Childrens Hospital and Johns Hopkins University have discovered that delivering a small molecule that is highly expressed in normal tissues but lost in diseased cells can result in tumor suppression.MicroRNAs (miRNA) are a class of small RNA molecules that are highly
Apr 15, 2009
Gene Therapy For Muscular Dystrophy Shows Promise Beyond Safety
Researchers have cleared a safety hurdle in efforts to develop a gene therapy for a form of muscular dystrophy that disables patients by gradually weakening muscles near the hips and shoulders.
Mar 27, 2009
FSH Society Fellowship Funds Facioscapulohumeral Muscular Dystrophy Research
Funding from the Facioscapulohumeral Muscular Dystrophy Society FSH Society, Inc. will help researchers determine the role a seldom-studied gene plays in the development and progression of facioscapulohumeral muscular dystrophy (FSHD), a debilitating muscular dystrophy often originating in the
Jan 26, 2009
St. Baldricks Foundation Awards $108,000 Grant to Nationwide Children's Hospital
St. Baldricks Foundation, a non-profit organization dedicated to raising money for childhood cancer research, awarded a grant of $108,000 to Nationwide Childrens Hospital.